BSE filing, NSE: MNIL. Summary written from the filing by ALFA Finder's alert engine.
Mega Nirman & Industries Ltd: key numbers
- Share price
- ₹45.62
- Market cap
- ₹117.0 Cr
- Revenue (annual)
- ₹14.79 Cr
- Net profit (annual)
- ₹0.35 Cr
- P/E (TTM)
- 207.2×Sector 43.1×
- Promoter holding
- 0.29%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Mega Nirman & Industries Ltd
All →Mega Nirman & Industries Other Announcement
The company filed its quarterly shareholding pattern for the period ended September 30, 2026, as required under SEBI regulations. This is a routine compliance disclosure.
Mega Nirman & Industries Business Update
Mega Nirman signed a Master Agreement with Safexpress to install and operate EV charging stations under its MEGACHARGE brand for Safexpress's logistics operations.
- From
- Safexpress Private Limited
Mega Nirman & Industries Partnership
Mega Nirman & Industries executed a Master EV Charging Services Agreement with Safexpress Private Limited. The framework agreement involves no committed aggregate contract value.
- From
- Safexpress Private Limited
- Execution
- 10 years per site, extendable by 3 years
Mega Nirman & Industries Management Change
Mega Nirman and Industries Limited has appointed Mr. Ishaan as a Non-Executive Non-Independent Director effective October 7, 2026 for a term of 12 months.
Mega Nirman & Industries Annual General Meeting
Mega Nirman & Industries Limited issued a Postal Ballot Notice seeking shareholder approval for the appointment of three directors and a rights issue of equity shares.
Mega Nirman & Industries Fund Raise of ₹50 Cr
Mega Nirman & Industries Ltd approved a rights issue of up to ₹50 Crore. The company also announced the appointment of an additional director.
- Value
- ₹50.00 Cr
Other board meeting date announcements
All →Patel Engineering Board Meeting Date
Patel Engineering has scheduled its Board meeting for November 5, 2026, to approve Q1 and H1 FY27 unaudited results. No financial figures or decisions are reported in this advance notice.
GKB Ophthalmics Board Meeting Date
GKB Ophthalmics scheduled its Board Meeting for November 12, 2026. The meeting will consider approving unaudited results for the September 30, 2026 quarter and half year.
Bombay Oxygen Investments Board Meeting Date
Board meeting scheduled for Nov 6, 2026 to approve Q1 and H1 FY27 unaudited results. Trading window closed for insiders Oct 1–Nov 8, 2026.
OCCL Board Meeting Date
OCCL Ltd has scheduled its Board meeting for 6 November 2026 to consider Q1 FY27 unaudited results and a possible interim dividend. The trading window for designated persons closed from 1 October 2026.
TCM Board Meeting Date
TCM Limited intimated a Board meeting for 06/11/2026 to approve Q2 FY27 results. The trading window will reopen 48 hours after the results declaration.
Mercury Laboratories Board Meeting Date
Mercury Laboratories scheduled its Board meeting for November 5, 2026, to approve Q2/H1 FY27 results. Trading window remains closed until 48 hours post-announcement.